Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Aug;3(4-5):212-5.

Contact diode laser cyclo-photocoagulation for refractory glaucoma. A pilot study

Affiliations
  • PMID: 7804105

Contact diode laser cyclo-photocoagulation for refractory glaucoma. A pilot study

M W Ulbig et al. Ger J Ophthalmol. 1994 Aug.

Abstract

Initial experience with non-contact diode cyclo-photocoagulation for refractory glaucoma has shown positive results. Diode laser irradiation applied via a contact probe results in greater transmission through the sclera and delivery of more energy to the ciliary body. A trial was performed to evaluate the effects of contact diode cyclo-photocoagulation. A total of 12 patients with glaucoma due to conditions such as central retinal vein occlusion were treated. A mean of 22 pulses (810 nm) with powers of up to 2 W and of 2 s duration were applied via a fibre-optic delivery system and a contact probe. The mean intra-ocular pressure dropped from 42.3 to 13.6 mmHg over 3 months. Four patients required retreatment. Three patients had side effects that included hyphaema, anterior fibrinous uveitis and pupil block. In conclusion, contact diode cyclo-photocoagulation had a significant ocular hypotensive action in the treatment of refractory glaucoma. As compared with non-contact diode cyclo-photocoagulation, the contact modality produced more marked non-therapeutic side effects.

PubMed Disclaimer

Publication types

LinkOut - more resources